IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v46y2023i7d10.1007_s40264-023-01302-7.html
   My bibliography  Save this article

Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review Update

Author

Listed:
  • Patricia García-Abeijon

    (University of Santiago de Compostela, Praza do Seminario de Estudos Galegos)

  • Catarina Costa

    (Universidade de Lisboa)

  • Margarita Taracido

    (University of Santiago de Compostela, Praza do Seminario de Estudos Galegos
    University of Santiago de Compostela
    Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiology and Public Health-CIBERESP))

  • Maria Teresa Herdeiro

    (University of Aveiro)

  • Carla Torre

    (Universidade de Lisboa
    Research Institute for Medicines (iMED.ULisboa))

  • Adolfo Figueiras

    (University of Santiago de Compostela, Praza do Seminario de Estudos Galegos
    University of Santiago de Compostela
    Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiology and Public Health-CIBERESP))

Abstract

Introduction Underreporting is a major limitation of the voluntary reporting system of adverse drug reactions (ADRs). A 2009 systematic review showed the knowledge and attitudes of health professionals were strongly related with underreporting of ADRs. Objective Our aim was to update our previous systematic review to determine factors (sociodemographic, knowledge and attitudes) associated with the underreporting of ADRs by healthcare professionals. Methods We searched the MEDLINE and EMBASE databases for studies published between 2007 and 2021 that met the following inclusion criteria: (1) published in English, French, Portuguese or Spanish; (2) involving health professionals; and (3) the goal was to evaluate factors associated with underreporting of ADRs through spontaneous reporting. Results Overall, 65 papers were included. While health professional sociodemographic characteristics did not influence underreporting, knowledge and attitudes continue to show a significant effect: (1) ignorance (only serious ADRs need to be reported) in 86.2%; (2) lethargy (procrastination, lack of interest, and other excuses) in 84.6%; (3) complacency (the belief that only well tolerated drugs are allowed on the market) in 46.2%; (4) diffidence (fear of appearing ridiculous for reporting merely suspected ADRs) in 44.6%; and (5) insecurity (it is nearly impossible to determine whether or not a drug is responsible for a specific adverse reaction) in 33.8%, and the absence of feedback in 9.2%. In this review, the non-obligation to reporting and confidentiality emerge as new reasons for underreporting. Conclusions Attitudes regarding the reporting of adverse reactions continue to be the main determinants of underreporting. Even though these are potentially modifiable factors through educational interventions, minimal changes have been observed since 2009. Clinical Trials Registration PROSPERO registration number CRD42021227944.

Suggested Citation

  • Patricia García-Abeijon & Catarina Costa & Margarita Taracido & Maria Teresa Herdeiro & Carla Torre & Adolfo Figueiras, 2023. "Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review Update," Drug Safety, Springer, vol. 46(7), pages 625-636, July.
    • Handle: RePEc:spr:drugsa:v:46:y:2023:i:7:d:10.1007_s40264-023-01302-7
    DOI: 10.1007/s40264-023-01302-7
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-023-01302-7
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40264-023-01302-7?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Stella Stergiopoulos & Carrie A. Brown & Thomas Felix & Gustavo Grampp & Kenneth A. Getz, 2016. "A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals," Drug Safety, Springer, vol. 39(11), pages 1117-1127, November.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Didrik Wessel & Nicolai Pogrebnyakov, 2024. "Using Social Media as a Source of Real-World Data for Pharmaceutical Drug Development and Regulatory Decision Making," Drug Safety, Springer, vol. 47(5), pages 495-511, May.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Karen Smith & Su Golder & Abeed Sarker & Yoon Loke & Karen O’Connor & Graciela Gonzalez-Hernandez, 2018. "Methods to Compare Adverse Events in Twitter to FAERS, Drug Information Databases, and Systematic Reviews: Proof of Concept with Adalimumab," Drug Safety, Springer, vol. 41(12), pages 1397-1410, December.
    2. Solomon Shiferaw Nadew & Kidanemariam G/Michael Beyene & Solomon Worku Beza, 2020. "Adverse drug reaction reporting practice and associated factors among medical doctors in government hospitals in Addis Ababa, Ethiopia," PLOS ONE, Public Library of Science, vol. 15(1), pages 1-19, January.
    3. Alaa M. Abu Alrub & Yasser Sami Amer & Maher Abdelraheim Titi & Aisha Charmaine A. May & Farheen Shaikh & Maram M. Baksh & Fadi El‐Jardali, 2022. "Barriers and enablers in implementing an electronic incident reporting system in a teaching hospital: A case study from Saudi Arabia," International Journal of Health Planning and Management, Wiley Blackwell, vol. 37(2), pages 854-872, March.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:46:y:2023:i:7:d:10.1007_s40264-023-01302-7. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.